UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Crystal Structure of the Human Cannabinoid Receptor CB1

Cell, 2016-10, Vol.167 (3), p.750-762.e14

2016

Volltextzugriff (PDF)

Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists

Biochemistry (Easton), 2022-09, Vol.61 (18), p.1923-1935

2022

Volltextzugriff (PDF)

Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures

Cell, 2020-02, Vol.180 (4), p.655-665.e18

2020

Volltextzugriff (PDF)

Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria

Science signaling, 2016-11, Vol.9 (456), p.ra117

2016

Volltextzugriff (PDF)

A novel method for analyzing extremely biased agonism at G protein-coupled receptors

Molecular pharmacology, 2015-05, Vol.87 (5), p.866-877

2015

Volltextzugriff (PDF)

Decaf or regular? Energizing the caffeine receptor

Cell, 2021-04, Vol.184 (7), p.1659-1660

2021

Volltextzugriff (PDF)

G protein signaling–biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists

Proceedings of the National Academy of Sciences - PNAS, 2021-11, Vol.118 (48), p.1-11

2021

Volltextzugriff (PDF)

A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal

Neuropsychopharmacology (New York, N.Y.), 2020-01, Vol.45 (2), p.416-425

2020

Volltextzugriff (PDF)

Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation

Molecular psychiatry, 2020-09, Vol.25 (9), p.2086-2100

2020

Volltextzugriff (PDF)

Synthesis and evaluation of 3,4,5-trisubstituted triazoles as G protein-biased kappa opioid receptor agonists

European journal of medicinal chemistry, 2024-10, Vol.276, p.116627, Article 116627

2024

Volltextzugriff (PDF)

G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons

Science signaling, 2018-08, Vol.11 (542)

2018

Volltextzugriff (PDF)

Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors

The Journal of biological chemistry, 2013-12, Vol.288 (51), p.36703-36716

2013

Volltextzugriff (PDF)

A Route to Potent, Selective, and Biased Salvinorin Chemical Space

ACS central science, 2023-08, Vol.9 (8), p.1567-1574

2023

Volltextzugriff (PDF)

Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine

Biomolecules (Basel, Switzerland), 2023-06, Vol.13 (6), p.935

2023

Volltextzugriff (PDF)

Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development

Pharmacological research, 2017-11, Vol.125 (Pt B), p.161-177

2017

Volltextzugriff (PDF)

Approaches to Assess Biased Signaling at the CB1R Receptor

Methods in enzymology, 2017, Vol.593, p.259-279

2017

Volltextzugriff (PDF)

Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting

Neuropharmacology, 2015-12, Vol.99, p.131-141

2015

Volltextzugriff (PDF)

Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist

Molecular pharmacology, 2019-11, Vol.96 (5), p.619-628

2019

Volltextzugriff (PDF)

Probing the CB 1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist

Molecular pharmacology, 2019-11, Vol.96 (5), p.619-628

2019

Volltextzugriff (PDF)

Structure–Activity Relationship Studies of Functionally Selective Kappa Opioid Receptor Agonists that Modulate ERK 1/2 Phosphorylation While Preserving G Protein Over βArrestin2 Signaling Bias

ACS chemical neuroscience, 2015-08, Vol.6 (8), p.1411-1419

2015

Volltextzugriff (PDF)

Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development

Pharmacological research, 2017-11, Vol.125 (Pt B), p.161-177

2017

Volltextzugriff (PDF)

Correction to “Structure–Activity Relationship Studies of Functionally Selective Kappa Opioid Receptor Agonists that Modulate ERK 1/2 Phosphorylation While Preserving G Protein Over βArrestin2 Signaling Bias”

ACS chemical neuroscience, 2017-07, Vol.8 (7), p.1628-1628

2017

Volltextzugriff (PDF)

Novel allosteric effects of amiodarone at the muscarinic M5 receptor

The Journal of pharmacology and experimental therapeutics, 2010-07, Vol.334 (1), p.214

2010

Volltextzugriff (PDF)

Novel Allosteric Effects of Amiodarone at the Muscarinic M 5 Receptor

The Journal of pharmacology and experimental therapeutics, 2010-07, Vol.334 (1), p.214-222

2010

Volltextzugriff (PDF)

Functional analysis of key residues involved in CB1 and CB2 activation

The FASEB journal, 2022-05, Vol.36 (S1), p.n/a

2022

Volltextzugriff (PDF)

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(200)
Mit Volltextzugriff
(199)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(135)
Life Sciences & Biomedicine
(103)
Humans
(75)
Male
(42)
Animals
(36)
Female
(36)
Adult
(22)
Biological And Medical Sciences
(22)
Biochemistry & Molecular Biology
(20)
Middle Aged
(20)
Physical Sciences
(18)
Risk Factors
(15)
Medical Sciences
(14)
Science & Technology - Other Topics
(14)
Technology
(14)
Aged
(13)
Surgery
(13)
Fundamental And Applied Biological Sciences. Psychology
(12)
Mice
(12)
Multidisciplinary Sciences
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Crystal Structure of the Human Cannabinoid Receptor CB1

Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists

Activation and Signaling Mechanism Revealed by Cannabinoid Receptor-Gi Complex Structures

Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria

A novel method for analyzing extremely biased agonism at G protein-coupled receptors

Decaf or regular? Energizing the caffeine receptor

G protein signaling–biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists

A G protein signaling-biased agonist at the μ-opioid receptor reverses morphine tolerance while preventing morphine withdrawal

Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation

Synthesis and evaluation of 3,4,5-trisubstituted triazoles as G protein-biased kappa opioid receptor agonists

G protein signaling-biased agonism at the κ-opioid receptor is maintained in striatal neurons

Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors

A Route to Potent, Selective, and Biased Salvinorin Chemical Space

Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine

Characterization of structurally novel G protein biased CB1 agonists: Implications for drug development

Approaches to Assess Biased Signaling at the CB1R Receptor

Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting

Probing the CB1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist

Probing the CB 1 Cannabinoid Receptor Binding Pocket with AM6538, a High-Affinity Irreversible Antagonist

Structure–Activity Relationship Studies of Functionally Selective Kappa Opioid Receptor Agonists that Modulate ERK 1/2 Phosphorylation While Preserving G Protein Over βArrestin2 Signaling Bias

Characterization of structurally novel G protein biased CB 1 agonists: Implications for drug development

Correction to “Structure–Activity Relationship Studies of Functionally Selective Kappa Opioid Receptor Agonists that Modulate ERK 1/2 Phosphorylation While Preserving G Protein Over βArrestin2 Signaling Bias”

Novel allosteric effects of amiodarone at the muscarinic M5 receptor

Novel Allosteric Effects of Amiodarone at the Muscarinic M 5 Receptor

Functional analysis of key residues involved in CB1 and CB2 activation

Suchergebnisse filtern